{"entity":{"type":"insider","cik":"0001405128","url":"/insider/0001405128","json_url":"/insider/0001405128.json","name":"Wegman Toby","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":49,"n_filings":26,"first":"2008-02-05","last":"2019-09-10","span_basis":"filed_date"},"name_variants":[{"name":"Wegman Toby","source":"filing","n_filings":26,"first_seen":"2008-02-05","last_seen":"2019-09-10"}],"transactions":[{"id":8440560,"accession":"0001062993-19-003653","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-19-003653","line_url":"/filing/0001062993-19-003653#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8900.0,"shares_display":"8,900","price_per_share":55.16,"price_display":"55.16","price_state":"stated","total_value":490924.0,"total_display":"490,924.00","total_whole":"490,924","shares_owned_after":935073.0,"shares_owned_after_display":"935,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-10","filed_date":"2019-09-10","scope":"insider"},{"id":8440557,"accession":"0001062993-19-003653","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-19-003653","line_url":"/filing/0001062993-19-003653#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1100.0,"shares_display":"1,100","price_per_share":55.23,"price_display":"55.23","price_state":"stated","total_value":60753.0,"total_display":"60,753.00","total_whole":"60,753","shares_owned_after":943973.0,"shares_owned_after_display":"943,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-09","filed_date":"2019-09-10","scope":"insider"},{"id":7833124,"accession":"0001062993-19-002375","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-19-002375","line_url":"/filing/0001062993-19-002375","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5500.0,"shares_display":"5,500","price_per_share":64.06422545454545,"price_display":"64.06","price_state":"stated","total_value":352353.24,"total_display":"352,353.24","total_whole":"352,353","shares_owned_after":945173.0,"shares_owned_after_display":"945,173","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-05-21","filed_date":"2019-05-22","scope":"insider","n_lines":2},{"id":6256116,"accession":"0001062993-18-003491","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-18-003491","line_url":"/filing/0001062993-18-003491#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2500.0,"shares_display":"2,500","price_per_share":51.8912,"price_display":"51.89","price_state":"stated","total_value":129728.0,"total_display":"129,728.00","total_whole":"129,728","shares_owned_after":947473.0,"shares_owned_after_display":"947,473","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-08-17","filed_date":"2018-08-17","scope":"insider"},{"id":3242620,"accession":"0001062993-16-012534","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-012534","line_url":"/filing/0001062993-16-012534#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":48.0832,"price_display":"48.08","price_state":"stated","total_value":480832.0,"total_display":"480,832.00","total_whole":"480,832","shares_owned_after":949973.0,"shares_owned_after_display":"949,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-11-29","filed_date":"2016-11-29","scope":"insider"},{"id":2504831,"accession":"0001062993-16-011508","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011508","line_url":"/filing/0001062993-16-011508#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3100.0,"shares_display":"3,100","price_per_share":41.21,"price_display":"41.21","price_state":"stated","total_value":127751.0,"total_display":"127,751.00","total_whole":"127,751","shares_owned_after":959973.0,"shares_owned_after_display":"959,973","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-15","filed_date":"2016-09-16","scope":"insider"},{"id":3276830,"accession":"0001062993-16-011441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011441","line_url":"/filing/0001062993-16-011441#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3605.0,"shares_display":"3,605","price_per_share":37.545,"price_display":"37.54","price_state":"stated","total_value":135349.725,"total_display":"135,349.72","total_whole":"135,350","shares_owned_after":963073.0,"shares_owned_after_display":"963,073","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-13","filed_date":"2016-09-13","scope":"insider"},{"id":2629743,"accession":"0001062993-16-011378","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-16-011378","line_url":"/filing/0001062993-16-011378#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Officer (President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1266.0,"shares_display":"1,266","price_per_share":37.5,"price_display":"37.50","price_state":"stated","total_value":47475.0,"total_display":"47,475.00","total_whole":"47,475","shares_owned_after":966678.0,"shares_owned_after_display":"966,678","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-02","filed_date":"2016-09-02","scope":"insider"},{"id":2629736,"accession":"0001062993-16-011378","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011378","line_url":"/filing/0001062993-16-011378#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Officer (President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7935.0,"shares_display":"7,935","price_per_share":37.533,"price_display":"37.53","price_state":"stated","total_value":297824.355,"total_display":"297,824.36","total_whole":"297,824","shares_owned_after":967944.0,"shares_owned_after_display":"967,944","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-09-01","filed_date":"2016-09-02","scope":"insider"},{"id":2083647,"accession":"0001062993-16-011355","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-16-011355","line_url":"/filing/0001062993-16-011355#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Officer (President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2692.0,"shares_display":"2,692","price_per_share":37.5027,"price_display":"37.50","price_state":"stated","total_value":100957.2684,"total_display":"100,957.27","total_whole":"100,957","shares_owned_after":975879.0,"shares_owned_after_display":"975,879","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-30","filed_date":"2016-08-30","scope":"insider"},{"id":2083645,"accession":"0001062993-16-011355","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-16-011355","line_url":"/filing/0001062993-16-011355#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Officer (President), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President","security_title":"Common Stock, $.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1607.0,"shares_display":"1,607","price_per_share":37.6107,"price_display":"37.61","price_state":"stated","total_value":60440.3949,"total_display":"60,440.39","total_whole":"60,440","shares_owned_after":978571.0,"shares_owned_after_display":"978,571","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-08-29","filed_date":"2016-08-30","scope":"insider"},{"id":3242605,"accession":"0001062993-16-009883","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-16-009883","line_url":"/filing/0001062993-16-009883","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":25000.0,"shares_display":"25,000","price_per_share":33.01066,"price_display":"33.01","price_state":"stated","total_value":825266.5,"total_display":"825,266.50","total_whole":"825,267","shares_owned_after":980178.0,"shares_owned_after_display":"980,178","ownership_form":"I","is_10b5_1":null,"transaction_date":"2016-05-18","filed_date":"2016-05-19","scope":"insider","n_lines":4},{"id":9219055,"accession":"0001062993-15-002351","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-15-002351","line_url":"/filing/0001062993-15-002351#line-1","is_derivative":false,"issuer_cik":"0001405128","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0001405128","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Coomon Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2950.0,"shares_display":"2,950","price_per_share":39.39,"price_display":"39.39","price_state":"stated","total_value":116200.5,"total_display":"116,200.50","total_whole":"116,201","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2015-05-04","scope":"insider"},{"id":6599590,"accession":"0001062993-14-007012","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-14-007012","line_url":"/filing/0001062993-14-007012#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2950.0,"shares_display":"2,950","price_per_share":39.39,"price_display":"39.39","price_state":"stated","total_value":116200.5,"total_display":"116,200.50","total_whole":"116,201","shares_owned_after":1714.0,"shares_owned_after_display":"1,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-02","filed_date":"2014-12-04","scope":"insider"},{"id":6757133,"accession":"0001062993-14-006903","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001062993-14-006903","line_url":"/filing/0001062993-14-006903#line-3","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2050.0,"shares_display":"2,050","price_per_share":39.259,"price_display":"39.26","price_state":"stated","total_value":80480.95,"total_display":"80,480.95","total_whole":"80,481","shares_owned_after":4664.0,"shares_owned_after_display":"4,664","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-24","filed_date":"2014-11-25","scope":"insider"},{"id":6757130,"accession":"0001062993-14-006903","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-14-006903","line_url":"/filing/0001062993-14-006903#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10000.0,"shares_display":"10,000","price_per_share":39.0369,"price_display":"39.04","price_state":"stated","total_value":390369.0,"total_display":"390,369.00","total_whole":"390,369","shares_owned_after":6714.0,"shares_owned_after_display":"6,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-11-21","filed_date":"2014-11-25","scope":"insider"},{"id":2540421,"accession":"0001062993-12-002148","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001062993-12-002148","line_url":"/filing/0001062993-12-002148","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1963.0,"shares_display":"1,963","price_per_share":18.106620631686194,"price_display":"18.11","price_state":"stated","total_value":35543.2963,"total_display":"35,543.30","total_whole":"35,543","shares_owned_after":1714.0,"shares_owned_after_display":"1,714","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-15","filed_date":"2012-06-18","scope":"insider","n_lines":3},{"id":2540406,"accession":"0001062993-12-002148","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001062993-12-002148","line_url":"/filing/0001062993-12-002148","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4376.0,"shares_display":"4,376","price_per_share":18.44590265082267,"price_display":"18.45","price_state":"stated","total_value":80719.27,"total_display":"80,719.27","total_whole":"80,719","shares_owned_after":6553.0,"shares_owned_after_display":"6,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-14","filed_date":"2012-06-18","scope":"insider","n_lines":6},{"id":2612313,"accession":"0001062993-12-002080","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-12-002080","line_url":"/filing/0001062993-12-002080#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":18.21,"price_display":"18.21","price_state":"stated","total_value":27315.0,"total_display":"27,315.00","total_whole":"27,315","shares_owned_after":8053.0,"shares_owned_after_display":"8,053","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-11","filed_date":"2012-06-13","scope":"insider"},{"id":2082705,"accession":"0001062993-12-002051","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-12-002051","line_url":"/filing/0001062993-12-002051#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101.0,"shares_display":"101","price_per_share":17.74,"price_display":"17.74","price_state":"stated","total_value":1791.74,"total_display":"1,791.74","total_whole":"1,792","shares_owned_after":9553.0,"shares_owned_after_display":"9,553","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-06","filed_date":"2012-06-08","scope":"insider"},{"id":2384948,"accession":"0001062993-12-002031","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001062993-12-002031","line_url":"/filing/0001062993-12-002031","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1500.0,"shares_display":"1,500","price_per_share":17.353733333333334,"price_display":"17.35","price_state":"stated","total_value":26030.6,"total_display":"26,030.60","total_whole":"26,031","shares_owned_after":9654.0,"shares_owned_after_display":"9,654","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-04","filed_date":"2012-06-05","scope":"insider","n_lines":3},{"id":2384931,"accession":"0001062993-12-002031","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-12-002031","line_url":"/filing/0001062993-12-002031#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.75,"price_display":"16.75","price_state":"stated","total_value":16750.0,"total_display":"16,750.00","total_whole":"16,750","shares_owned_after":11154.0,"shares_owned_after_display":"11,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-06-01","filed_date":"2012-06-05","scope":"insider"},{"id":2941507,"accession":"0001062993-12-001996","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-12-001996","line_url":"/filing/0001062993-12-001996#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21.0,"shares_display":"21","price_per_share":21.1,"price_display":"21.10","price_state":"stated","total_value":443.1,"total_display":"443.10","total_whole":"443","shares_owned_after":12154.0,"shares_owned_after_display":"12,154","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-30","filed_date":"2012-05-31","scope":"insider"},{"id":2941503,"accession":"0001062993-12-001996","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-12-001996","line_url":"/filing/0001062993-12-001996#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100.0,"shares_display":"100","price_per_share":17.0,"price_display":"17.00","price_state":"stated","total_value":1700.0,"total_display":"1,700.00","total_whole":"1,700","shares_owned_after":12175.0,"shares_owned_after_display":"12,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-29","filed_date":"2012-05-31","scope":"insider"},{"id":2999535,"accession":"0001062993-12-001908","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-12-001908","line_url":"/filing/0001062993-12-001908#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1000.0,"shares_display":"1,000","price_per_share":16.25,"price_display":"16.25","price_state":"stated","total_value":16250.0,"total_display":"16,250.00","total_whole":"16,250","shares_owned_after":12275.0,"shares_owned_after_display":"12,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-22","filed_date":"2012-05-24","scope":"insider"},{"id":2133740,"accession":"0001062993-12-001874","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-12-001874","line_url":"/filing/0001062993-12-001874#line-2","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1025.0,"shares_display":"1,025","price_per_share":15.6289,"price_display":"15.63","price_state":"stated","total_value":16019.6225,"total_display":"16,019.62","total_whole":"16,020","shares_owned_after":13275.0,"shares_owned_after_display":"13,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-17","filed_date":"2012-05-18","scope":"insider"},{"id":2133735,"accession":"0001062993-12-001874","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-12-001874","line_url":"/filing/0001062993-12-001874#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":700.0,"shares_display":"700","price_per_share":16.5298,"price_display":"16.53","price_state":"stated","total_value":11570.86,"total_display":"11,570.86","total_whole":"11,571","shares_owned_after":14300.0,"shares_owned_after_display":"14,300","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-05-16","filed_date":"2012-05-18","scope":"insider"},{"id":7642508,"accession":"0001062993-10-003043","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001062993-10-003043","line_url":"/filing/0001062993-10-003043#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":150000.0,"shares_display":"150,000","price_per_share":23.5,"price_display":"23.50","price_state":"stated","total_value":3525000.0,"total_display":"3,525,000.00","total_whole":"3,525,000","shares_owned_after":1005179.0,"shares_owned_after_display":"1,005,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-09-13","filed_date":"2010-09-15","scope":"insider"},{"id":5617364,"accession":"0001204459-09-002291","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001204459-09-002291","line_url":"/filing/0001204459-09-002291#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":30.0,"price_display":"30.00","price_state":"stated","total_value":3000000.0,"total_display":"3,000,000.00","total_whole":"3,000,000","shares_owned_after":1155179.0,"shares_owned_after_display":"1,155,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-11-27","filed_date":"2009-12-01","scope":"insider"},{"id":5709605,"accession":"0001204459-09-001688","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001204459-09-001688","line_url":"/filing/0001204459-09-001688#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":100000.0,"shares_display":"100,000","price_per_share":24.0,"price_display":"24.00","price_state":"stated","total_value":2400000.0,"total_display":"2,400,000.00","total_whole":"2,400,000","shares_owned_after":1255179.0,"shares_owned_after_display":"1,255,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-09-15","filed_date":"2009-09-17","scope":"insider"},{"id":5673604,"accession":"0001204459-09-000228","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001204459-09-000228","line_url":"/filing/0001204459-09-000228#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.NGM","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":45000.0,"shares_display":"45,000","price_per_share":20.0,"price_display":"20.00","price_state":"stated","total_value":900000.0,"total_display":"900,000.00","total_whole":"900,000","shares_owned_after":1355179.0,"shares_owned_after_display":"1,355,179","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-02-05","filed_date":"2009-02-11","scope":"insider"},{"id":9211939,"accession":"0000950120-08-000149","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000149","line_url":"/filing/0000950120-08-000149#line-1","is_derivative":false,"issuer_cik":"0001405128","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.OB","issuer_name_source":null,"issuer_url":"/issuer/0001405128","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":2200000.0,"total_display":"2,200,000.00","total_whole":"2,200,000","shares_owned_after":1024997.0,"shares_owned_after_display":"1,024,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-07","filed_date":"2008-04-09","scope":"insider"},{"id":4008529,"accession":"0000950120-08-000143","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000950120-08-000143","line_url":"/filing/0000950120-08-000143#line-1","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.OB","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":200000.0,"shares_display":"200,000","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":2200000.0,"total_display":"2,200,000.00","total_whole":"2,200,000","shares_owned_after":1230111.0,"shares_owned_after_display":"1,230,111","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-04-07","filed_date":"2008-04-09","scope":"insider"},{"id":2451024,"accession":"0000950120-08-000054","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000950120-08-000054","line_url":"/filing/0000950120-08-000054","is_derivative":false,"issuer_cik":"0000875622","issuer_name":"BIOSPECIFICS TECHNOLOGIES CORP","issuer_ticker":"BSTC.OB","issuer_name_source":null,"issuer_url":"/issuer/0000875622","owner_cik":"0001405128","owner_name":"Wegman Toby","owner_display_name":"Wegman Toby","owner_url":"/insider/0001405128","role":"Director, Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":344114.0,"shares_display":"344,114","price_per_share":12.0,"price_display":"12.00","price_state":"stated","total_value":4129368.0,"total_display":"4,129,368.00","total_whole":"4,129,368","shares_owned_after":1224997.0,"shares_owned_after_display":"1,224,997","ownership_form":"I","is_10b5_1":null,"transaction_date":"2008-02-01","filed_date":"2008-02-05","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":49,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":49,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":49},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000875622","name":"BIOSPECIFICS TECHNOLOGIES CORP","url":"/issuer/0000875622","role":"Director, Officer (President), Ten percent owner","n_filings":26,"first_seen":"2008-02-05","last_seen":"2019-09-10"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001405128","retrieved_at":"2026-08-26T13:35:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}